Press release
Pulmonary Surfactant Market is estimated to grow at a CAGR of 4.98% during the forecast period of 2023-2030 : Cognitive Market Research
Pulmonary Surfactant Market is estimated to grow at a CAGR of 4.98% during the period of 2023-2030 : Cognitive Market Research
- Pulmonary surfactant usually is surface-active lipoprotein compound that is designed by type II alveolar cells. Hydrophilic and hydrophobic regions have both proteins as well as lipids that form the surfactant. Pulmonary surfactant is important at all times because it lines the alveoli to lower physical phenomena, thereby preventing atelectasis throughout breathing.
Summary:
- The Global Pulmonary Surfactant market is estimated to be valued at USD 598.7 million in 2022 and is expected to exhibit a CAGR of 4.98% during the forecast period (2023-2030).
"To know more The Pulmonary Surfactant Market statistics click here: https://www.cognitivemarketresearch.com/pulmonary-surfactant-market-report
Market Dynamics:
- Increasing prevalence of animal derived surfactant for the treatment of respiratory distress is anticipated to drive the growth of the global pulmonary surfactant market. In addition, rising research & development activities to introduce advancement in pulmonary surfactant market drives the growth of the global market. However, increasing number of adverse effects associated with the pulmonary surfactant hamper the growth of the global market.
Market Segmentation:
Type:
• Synthetic Pulmonary Surfactant
• Animal Derived Surfactant
By type, the market is segmented into synthetic pulmonary surfactant and animal derived surfactants. Animal derived surfactant segment dominates the global market due to increasing incidence of respiratory diseases across the globe.
Drug Type:
• Poractant alfa
• Lucinactant
• Calfactant
By drug type, Poractant alfa segment dominates the global pulmonary surfactant market, due to higher benefits and lower complications.
Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By distribution channel, hospital pharmacies segment has the largest revenue share of global pulmonary surfactant market, due to reimbursement and cost of drugs are more advantageous in hospital pharmacies.
Indications:
• Respiratory Infections
• Obstructive lung Diseases
• Others (chronic lung disease of prematurity, and surfactant protein-B deficiency)
Respiratory infections segment dominates the global market, due to increasing prevalence rate of respiratory infections drives the demand for the growth of the target market.
Route of Administration:
• Intratracheal
• Injectable
The Major Players in Pulmonary Surfactant Market are:
Boehringer Ingelheim, AbbVie, Lyomark Pharma, Tekzima (Noargen), ONY Biotech, Abbott, Aviva Systems Biology, LSBio, Biomatik, Biorbyt, Reddot Biotech, XpressBio, Creative Diagnostics, Nanjing Norris Pharm Technology, Windtree Therapeutics
Get free sample pages of latest published Pulmonary Surfactant Report:
https://www.cognitivemarketresearch.com/pulmonary-surfactant-market-report#request_sample
News:
- J.K Lon, government children hospital launched less invasive surfactant administration (LISA) treatment
In May 2020, J.K Lon, government children hospital introduced less invasive surfactant administration (LISA) treatment for neonatal respiratory distress syndrome. Further, it minimizes the side effect caused due to long time exposure of ventilators. LISA technique is beneficial where the surfactant is directed via thin feeding tube and detached immediately after the procedure is finished.
Browse here for Full TOC:
Table of Content (Revenue USD Edition), (Enquire about Volume/Consumption Edition Data)
Chapter 1 Industrial Insight and Market Scope
Chapter 2 Research Methodology Review Complete Research Methodology
Chapter 3 Executive Summary of Pulmonary Surfactant Market
Chapter 4 Global Pulmonary Surfactant Market Overview
Chapter 5 Competitive Analysis (Subject to Availability)
• 5.1 Global Pulmonary Surfactant Market Revenue and Share by Manufacturers (2018-2022)
• 5.2 Global Pulmonary Surfactant Industry Mergers and Acquisition Analysis
• 5.2 Global Pulmonary Surfactant New Launches Analysis
Chapter 6 Qualitative Analysis
Chapter 7 Company Profiling (Subject to Availability)
Chapter 8 Global Pulmonary Surfactant Market by Type Segmentation Analysis (2018-2030)
Chapter 9 Global Pulmonary Surfactant Market by Application Segmentation Analysis (2018-2030)
Chapter 10 Global Pulmonary Surfactant Market by Drug Type Segmentation Analysis (2018-2030)
Chapter 11 Global Pulmonary Surfactant Market by Distribution Channel Segmentation Analysis (2018-2030)
Chapter 12 Global Pulmonary Surfactant Market by Indications Segmentation Analysis (2018-2030)
Chapter 13 Global Pulmonary Surfactant Market by Route of Administration Segmentation Analysis (2018-2030)
Chapter 14 Global Pulmonary Surfactant Market Regional Analysis
• 14.1 Detailed Qualitative Analysis
• 14.2 Global Pulmonary Surfactant Market Revenue by Region (2018-2030)
• 14.2 Global Pulmonary Surfactant Market Share (%) by Region (2018-2030)
Chapter 15 North America Pulmonary Surfactant Market Outlook (2018 - 2030)
Chapter 16 Europe Pulmonary Surfactant Market Outlook (2018 - 2030)
Chapter 17 Asia Pacific Pulmonary Surfactant Market Outlook (2018 - 2030)
Chapter 18 Latin America Pulmonary Surfactant Market Outlook (2018 - 2030)
Chapter 19 Middle East and Africa Pulmonary Surfactant Market Outlook (2018 - 2030)
Chapter 20 Research Findings
To know more Pulmonary Surfactant Market TOC click here: https://www.cognitivemarketresearch.com/pulmonary-surfactant-market-report#table_of_contents
Related report:
• Acute Respiratory Distress Syndrome Therapeutics Market - https://www.cognitivemarketresearch.com/acute-respiratory-distress-syndrome-therapeutics-market-report
• Pulmonary Fibrosis Drug Market - https://www.cognitivemarketresearch.com/pulmonary-fibrosis-drug-market-report
• Pulmonary Drug Delivery Systems Market - https://www.cognitivemarketresearch.com/pulmonary-drug-delivery-systems-market-report
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Nicolas Shaw
Cognitive Market Research
20 N State Street,Chicago,
Illinois, 60602
United States
USA: +1 312-376-8303
Europe and UK: (+44) 20-8144-9523
Asia Pacific: (+852) 81930785
Email: sales@cognitivemarketresearch.com
Website: https://www.cognitivemarketresearch.com/about-us
About Cognitive Market Research Company :
Cognitive Market Research has evolved as one leading market research and consulting firm and it provides services across multiple domains. Cognitive Market Research gathers and analyzes data about customers, competitors, distributors, and other market actors and forces operational across the value chain. As a market research company, we follow a complete process of gathering information about the target market and end-use industries to verify the complete journey of the product or service in the global market. It helps our readers understand the demand and viability of their product/service and how it might perform in the real world and help them to build business strategies accordingly.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pulmonary Surfactant Market is estimated to grow at a CAGR of 4.98% during the forecast period of 2023-2030 : Cognitive Market Research here
News-ID: 2955448 • Views: …
More Releases from Cognitive Market Research
Ultra Fine Copper Powder Market is estimated to grow at a CAGR of 7.1% during th …
Market Overview:
- The term "ultra-fine copper powder" refers to a finely divided type of copper that is distinguished by its exceedingly small particle size and large surface area. It is made using a variety of processes, such as mechanical grinding, electrolysis, and chemical precipitation. Ultra-fine copper powder typically has particles between a few nanometres and a few micrometers in size.
Summary:
- As per Cognitive Market Research, Global Ultra-Fine Copper…
Premium Branding and Status Symbol boosts the Global Metal Card Market: Cognitiv …
Market Overview:
- A metal card typically refers to a credit or debit card that is made from metal materials instead of traditional plastic. These cards are often associated with premium or high-end credit card offerings and are designed to provide a more luxurious and prestigious feel. Metal cards are usually made from materials such as stainless steel, titanium, or other alloys, which gives them a solid and durable construction.…
Slot Machines Market is projected to grow at a CAGR of 12.9% within the forecast …
Market Overview:
A slot machine is operated by inserting coins into a slot and by pulling down on a long handle. It features a set of spinning reels with various symbols on them. Players or individuals insert coins or tokens into the machine and then pull a lever or press a button to activate the reels. The earliest slot machine technology was created with mechanical reels powered by random number generators.…
Mechanical Seals Market is estimated to grow at a CAGR of 4.8% within the foreca …
Market Overview:
A mechanical seal is only a way to keep fluid inside a vessel usually pumps, mixers, etc. when a rotating shaft passes through a stationary housing or, on rare occasions, when the housing rotates around the shaft. Mechanical seals are devices used to prevent leakage between two components or systems that are connected by a rotating shaft. They are commonly used in pumps, compressors, mixers, and other equipment that…
More Releases for Pulmonary
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers…
Global Pulmonary Embolism Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pulmonary Embolism Market is exhibited at USD 1.59 billion in 2023 and is projected to surpass USD 3.15 billion in 2028, anticipated to grow at a CAGR of 8.4% from 2023 to 2028.
The rapid increase in the prevalence of cancer, increasing investment for healthcare infrastructure and rising research and development activities, high disposable income, rising demand…
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of…
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated…
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments…
